-
2
-
-
77955277111
-
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: A retrospective consortium analysis
-
W. De Roock, B. Claes, D. Bernasconi, and et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis Lancet Oncol 11 2010 753 762
-
(2010)
Lancet Oncol
, vol.11
, pp. 753-762
-
-
De Roock, W.1
Claes, B.2
Bernasconi, D.3
-
3
-
-
84881640407
-
Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication
-
P. Lochhead, A. Kuchiba, Y. Imamura, and et al. Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication J Natl Cancer Inst 105 2013 1151 1156
-
(2013)
J Natl Cancer Inst
, vol.105
, pp. 1151-1156
-
-
Lochhead, P.1
Kuchiba, A.2
Imamura, Y.3
-
4
-
-
53049087109
-
Genomic and epigenetic instability in colorectal cancer pathogenesis
-
W.M. Grady, and J.M. Carethers Genomic and epigenetic instability in colorectal cancer pathogenesis Gastroenterology 135 2008 1079 1099
-
(2008)
Gastroenterology
, vol.135
, pp. 1079-1099
-
-
Grady, W.M.1
Carethers, J.M.2
-
5
-
-
0033587747
-
CpG island methylator phenotype in colorectal cancer
-
M. Toyota, N. Ahuja, M. Ohe-Toyota, J.G. Herman, S.B. Baylin, and J.P. Issa CpG island methylator phenotype in colorectal cancer Proc Natl Acad Sci USA 96 1999 8681 8686
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 8681-8686
-
-
Toyota, M.1
Ahuja, N.2
Ohe-Toyota, M.3
Herman, J.G.4
Baylin, S.B.5
Issa, J.P.6
-
6
-
-
0036242782
-
CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability
-
N. Hawkins, M. Norrie, K. Cheong, and et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability Gastroenterology 122 2002 1376 1387
-
(2002)
Gastroenterology
, vol.122
, pp. 1376-1387
-
-
Hawkins, N.1
Norrie, M.2
Cheong, K.3
-
7
-
-
34247570795
-
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample
-
S. Ogino, T. Kawasaki, G.J. Kirkner, P. Kraft, M. Loda, and C.S. Fuchs Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample J Mol Diagn 9 2007 305 314
-
(2007)
J Mol Diagn
, vol.9
, pp. 305-314
-
-
Ogino, S.1
Kawasaki, T.2
Kirkner, G.J.3
Kraft, P.4
Loda, M.5
Fuchs, C.S.6
-
8
-
-
33745541234
-
CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
-
D.J. Weisenberger, K.D. Siegmund, M. Campan, and et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer Nat Genet 38 2006 787 793
-
(2006)
Nat Genet
, vol.38
, pp. 787-793
-
-
Weisenberger, D.J.1
Siegmund, K.D.2
Campan, M.3
-
9
-
-
0036895068
-
Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
-
M. van Rijnsoever, F. Grieu, H. Elsaleh, D. Joseph, and B. Iacopetta Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands Gut 51 2002 797 802
-
(2002)
Gut
, vol.51
, pp. 797-802
-
-
Van Rijnsoever, M.1
Grieu, F.2
Elsaleh, H.3
Joseph, D.4
Iacopetta, B.5
-
10
-
-
79961137937
-
The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy
-
B.H. Min, J.M. Bae, E.J. Lee, and et al. The CpG island methylator phenotype may confer a survival benefit in patients with stage II or III colorectal carcinomas receiving fluoropyrimidine-based adjuvant chemotherapy BMC Cancer 11 2011 344
-
(2011)
BMC Cancer
, vol.11
, pp. 344
-
-
Min, B.H.1
Bae, J.M.2
Lee, E.J.3
-
11
-
-
84906935203
-
CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer
-
S. Shiovitz, M.M. Bertagnolli, L.A. Renfro, and et al. CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer Gastroenterology 147 2014 637 645
-
(2014)
Gastroenterology
, vol.147
, pp. 637-645
-
-
Shiovitz, S.1
Bertagnolli, M.M.2
Renfro, L.A.3
-
12
-
-
84922879141
-
Association between molecular subtypes of colorectal cancer and patient survival
-
A.I. Phipps, P.J. Limburg, J.A. Baron, and et al. Association between molecular subtypes of colorectal cancer and patient survival Gastroenterology 148 2015 77 87.e72
-
(2015)
Gastroenterology
, vol.148
, pp. 77-87e72
-
-
Phipps, A.I.1
Limburg, P.J.2
Baron, J.A.3
-
13
-
-
0041524111
-
CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer
-
M. Van Rijnsoever, H. Elsaleh, D. Joseph, K. McCaul, and B. Iacopetta CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer Clin Cancer Res 9 2003 2898 2903
-
(2003)
Clin Cancer Res
, vol.9
, pp. 2898-2903
-
-
Van Rijnsoever, M.1
Elsaleh, H.2
Joseph, D.3
McCaul, K.4
Iacopetta, B.5
-
14
-
-
35948981194
-
Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy
-
L. Shen, P.J. Catalano, A.B. Benson III, P. O'Dwyer, S.R. Hamilton, and J.P. Issa Association between DNA methylation and shortened survival in patients with advanced colorectal cancer treated with 5-fluorouracil based chemotherapy Clin Cancer Res 13 2007 6093 6098
-
(2007)
Clin Cancer Res
, vol.13
, pp. 6093-6098
-
-
Shen, L.1
Catalano, P.J.2
Benson, A.B.3
O'Dwyer, P.4
Hamilton, S.R.5
Issa, J.P.6
-
15
-
-
79953217628
-
5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer
-
R. Jover, T.P. Nguyen, L. Perez-Carbonell, and et al. 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer Gastroenterology 140 2011 1174 1181
-
(2011)
Gastroenterology
, vol.140
, pp. 1174-1181
-
-
Jover, R.1
Nguyen, T.P.2
Perez-Carbonell, L.3
-
16
-
-
84874106654
-
Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer
-
S.W. Han, H.J. Lee, J.M. Bae, and et al. Methylation and microsatellite status and recurrence following adjuvant FOLFOX in colorectal cancer Int J Cancer 132 2013 2209 2216
-
(2013)
Int J Cancer
, vol.132
, pp. 2209-2216
-
-
Han, S.W.1
Lee, H.J.2
Bae, J.M.3
-
17
-
-
85019194869
-
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
-
D. Pectasides, V. Karavasilis, G. Papaxoinis, and et al. Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer BMC Cancer 15 2015 384
-
(2015)
BMC Cancer
, vol.15
, pp. 384
-
-
Pectasides, D.1
Karavasilis, V.2
Papaxoinis, G.3
-
18
-
-
69549108768
-
RNA extraction from archival formalin-fixed paraffin-embedded tissue: A comparison of manual, semiautomated, and fully automated purification methods
-
K. Bohmann, G. Hennig, U. Rogel, and et al. RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods Clin Chem 55 2009 1719 1727
-
(2009)
Clin Chem
, vol.55
, pp. 1719-1727
-
-
Bohmann, K.1
Hennig, G.2
Rogel, U.3
-
19
-
-
33744550591
-
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis
-
S. Ogino, T. Kawasaki, M. Brahmandam, and et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis J Mol Diagn 8 2006 209 217
-
(2006)
J Mol Diagn
, vol.8
, pp. 209-217
-
-
Ogino, S.1
Kawasaki, T.2
Brahmandam, M.3
-
20
-
-
84929379762
-
Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: A prospective retrospective translational study in the context of a Hellenic Cooperative Oncology Group randomised trial
-
G. Pentheroudakis, G. Raptou, V. Kotoula, and et al. Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a Hellenic Cooperative Oncology Group randomised trial PloS One 10 2015 e0124612
-
(2015)
PloS One
, vol.10
, pp. e0124612
-
-
Pentheroudakis, G.1
Raptou, G.2
Kotoula, V.3
-
21
-
-
64649096900
-
Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803
-
M.M. Bertagnolli, D. Niedzwiecki, C.C. Compton, and et al. Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803 J Clin Oncol 27 2009 1814 1821
-
(2009)
J Clin Oncol
, vol.27
, pp. 1814-1821
-
-
Bertagnolli, M.M.1
Niedzwiecki, D.2
Compton, C.C.3
|